I agree that option 3 is a great thing to go, but the problem is that most people won't pay to have these tests done unless their insurance covers it. I doubt a

I agree that option 3 is a great thing to go, but the problem is that most people won't pay to have these tests done unless their insurance covers it. I doubt an insurance company will pay for it because it costs them more money to have regular screenings done if the individual is at higher risk, or the insurance company could drop coverage all together. It's unfortunate that the US health care system works this way. Also, I doubt people will decide to go get tested for increased risks for diseases unless their doctor recommends it; for most, ignorance is bliss, and they would rather not know. It's illogical, but that seems to be how a lot of people think. I think it's a good idea to pursue both options 1 and 3; option 1 will allow you to get a steady income to allow you to expand to other more "useful" tests in option 3 and to pay for their FDA approval. Once more tests are developed, a package option could be offered which tested for all mutations, both the "feel good" ones and the increased risk ones.